GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Series GSE41951 Query DataSets for GSE41951
Status Public on Feb 01, 2013
Title Gene expression profile of the human leukemia cell line Reh after treatment with bortezomib, valproic acid or a combination of both.
Organism Homo sapiens
Experiment type Expression profiling by array
Summary New therapy options are required for relapsed B-cell precursor ALL patients in order to improve survival and reduce adverse acute and late effects. We observed a synergistic anti-leukemic activity of concomitant treatment with bortezomib and valproic acid in BCP-ALL cells. In this experiment we aimed to identify the pathways modulated after concomitant treatment with bortezomib and valproic acid.
Overall design Reh cells treated with either bortezomib, valproic acid, or the combination of both normalized to a untreated control.
Contributor(s) Shalapour S
Citation(s) 23357978
Submission date Oct 31, 2012
Last update date Nov 27, 2018
Contact name Shabnam Shalapour
Organization name Charité - Universitätsmedizin Berlin
Street address Augustenburger Platz 1
City Berlin
ZIP/Postal code 13353
Country Germany
Platforms (1)
GPL13607 Agilent-028004 SurePrint G3 Human GE 8x60K Microarray (Feature Number version)
Samples (4)
GSM1028104 Reh cells_control_12h
GSM1028105 Reh cells_valproic acid_12h
GSM1028106 Reh cells_bortezomib_12h
BioProject PRJNA178578

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE41951_RAW.tar 53.9 Mb (http)(custom) TAR (of TXT)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap